David Raben, Chief Officer of Bicara Therapeutics BCAX, has filed 0 purchases and 8 sales on the open market. Over the past 12 months that comes to a net sale of $1.1M. The latest trade was on 04/27.

DR

DR

David Raben

Chief Medical Officer

Company

Bicara Therapeutics BCAX

First filing

25/11/25

Trades

27 trades

Buys / sales

0 / 8

12-month net buying

−$1.1M

Last trade

04/27

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Bicara TherapeuticsBCAX	Open-market sale10b5-1 plan	04/27	04/28	5,500 sh	$22.88	$125,840	−9.0%
Bicara TherapeuticsBCAX	Open-market sale10b5-1 plan	03/25	03/26	5,500 sh	$18.95	$104,225	−9.0%
Bicara TherapeuticsBCAX	Open-market sale10b5-1 plan	03/03–03/04	03/05	16,500 sh2 trades	$18.52avg.	$305,566	−23.0%
Bicara TherapeuticsBCAX	Open-market sale10b5-1 plan	25/11/24–25/11/25	25/11/25	11,000 sh3 trades	$18.65avg.	$205,095	−23.7%
Bicara TherapeuticsBCAX	Open-market sale10b5-1 plan	25/10/09	25/10/10	22,000 sh	$18.45	$405,900	−38.3%